CYTK- Cytokinetics, Incorporated
Cytokinetics, Incorporated (CYTK) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $30.63M | - | |
| VP | 157.4K | $12.04M | -3,500 | |
| CFO | 100.8K | $7.72M | - | |
| Other | 87.3K | $6.68M | - | |
| VP | 58.6K | $4.48M | - |
Activity
Buys and sells only
Transactions
10 filings · page 5
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $38.42 | $192,100.00 | -1.3% | +69.4% | - | |
| Aug 5, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $36.34 | $72,680.00 | -1.4% | +66.0% | +113.3% | |
| Jul 29, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $36.45 | $182,250.00 | -1.3% | +67.6% | +118.4% | |
| Jul 22, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $37.47 | $74,940.00 | -1.4% | +57.4% | +118.0% | |
| Jul 14, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $38.15 | $190,750.00 | -1.3% | +54.5% | +120.0% | |
| Jul 8, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $33.76 | $67,520.00 | -1.4% | +77.1% | +147.8% | |
| Jul 1, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $33.55 | $167,750.00 | -1.2% | +60.2% | +153.4% | |
| Jun 17, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $32.91 | $65,820.00 | -1.4% | +51.9% | +140.0% | |
| Jun 16, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $33.80 | $169,000.00 | -1.2% | +46.4% | +122.6% | |
| Jun 5, 2025 | Kaye Edward M. Md46 | Director | Sell | 3,636 | $32.10 | $116,715.60 | -10.9% | +55.8% | +122.8% |